Baxter International (BAX) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Baxter International · Health Care · ref. ETF XLV · 50 calls · price $25.93
What the company does: Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products.
📈 Baxter International (BAX) stock price
$25.93+6.3% over range
Aug 28, 25low $15.8 · high $28.35Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
25% recommend buying · 8 analysts
📊 JPI status : Baxter International has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 BAX price target & analyst consensus — price $25.93
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$29+11.8%
Median target · of 8 targets$26+0.3%
Lowest target · 1 firm of 8$21-19.0%
Current price$25.93
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
450%
$27 ↔ $29
Below
450%
$21 ↔ $25
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (299 calls tested). It aims for $28 (+8.0 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).
The 6 reliable analysts
$26.50+2.2 %
The 2 other firms
$25.50-1.7 %
How to read it: the 6 reliable firms are not filtered by optimism — 3 aim above the price, 3 below, hence their $26.50 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy225%
Hold675%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BAX price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on BAX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BAX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Baxter International? The JPI assistant answers using our backtest data.
💰 Baxter International dividend: yield, history & growth › open the full page
0.92%annual yield
That's ~$0.20 per share per year.
📈 Baxter International fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -9.3 %Revenue growth +5.3 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -16 %
2023
Rev −2%
2024
Rev −28%Profit −124%
2025
Rev +6%
🔎 Detailed analyses
🏛️ Which US Congress members hold Baxter International (BAX)?
3 Congress members have disclosed BAX buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on BAX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| BMO Capital ↗ | 100% | +18.0% | 5 |
| Piper Sandler ↗ | 100% | +14.1% | 4 |
| Goldman Sachs ↗ | 88% | +19.6% | 8 |
| UBS ↗ | 83% | +11.2% | 6 |
| Deutsche Bank ↗ | 67% | +18.1% | 3 |
| Wells Fargo ↗ | 62% | +3.2% | 8 |
| B of A Securities ↗ | 60% | -2.3% | 5 |
| Credit Suisse | 56% | +4.8% | 9 |
| Citigroup ↗ | 50% | -6.6% | 4 |
| Barclays ↗ | 45% | -4.8% | 20 |
See the other 7 firms
| Cowen & Co. | 0% | -14.7% | 2 |
| Keybanc ↗ | 8% | -20.3% | 12 |
| Raymond James ↗ | 17% | -14.5% | 12 |
| Stifel ↗ | 33% | -17.3% | 6 |
| Evercore ISI Group ↗ | 33% | -2.7% | 6 |
| JP Morgan ↗ | 43% | -2.0% | 7 |
| Morgan Stanley ↗ | 44% | -8.9% | 18 |
📊 What $1,000 invested in Baxter International would be worth › open the full page
In short — $1,000 invested in Baxter International 10 years ago would be worth $559 today, i.e. -6%/yr on average. Best year: 2017 (+46%), worst: 2022 (-41%). Price performance, excluding dividends.
If I'd invested $1,000 in Baxter International
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $731 | -27% |
| 3 years ago | $418 | -58% |
| 5 years ago | $266 | -73% |
Return by year (Baxter International)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +12% | $1,116 (+12%) |
| 2025 | -34% | $731 (-27%) |
| 2024 | -25% | $551 (-45%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Baxter International
Loading news…
📋 All analyst calls on BAX
Filtered on — · ✕ show all
■ Hold neutral · not a buy · 🎯$29
Price at call : $28.1 — gap to target +3%
Today : $25.93 — gap to target +12%
🎯 on BAX : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Wells Fargo ↗
Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $28.1 — gap to target -18%
Today : $25.93 — gap to target -11%
🎯 on BAX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Hold neutral · not a buy · 🎯$28
Price at call : $28.1 — gap to target -0%
Today : $25.93 — gap to target +8%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $26.16 — gap to target +7%
Today : $25.93 — gap to target +8%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Neutral neutral · not a buy · 🎯$25
Price at call : $24.77 — gap to target +1%
Today : $25.93 — gap to target -4%
🎯 on BAX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.77 — gap to target -3%
Today : $25.93 — gap to target -7%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.37 — gap to target -2%
Today : $25.93 — gap to target -7%
🎯 on BAX : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Goldman Sachs ↗
Jul 15, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $23.35 — gap to target -10%
Today : $25.93 — gap to target -19%
🎯 on BAX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
See the other 42 calls, newest to oldest
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$24
Price at call : $22.86 — upside +5%
Today : $25.93 — upside -7%
🎯 on BAX : 0% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▼ Sell · 🎯$17
Price at call : $18.78 — upside -9%
Today : $25.93 — upside -34%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Overweight · 🎯$27
Price at call : $16.75 — upside +61%
Today : $25.93 — upside +4%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$22
Price at call : $16.62 — upside +32%
Today : $25.93 — upside -15%
🎯 on BAX : 0% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.01 — gap to target +5%
Today : $25.93 — gap to target -27%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
Goldman Sachs ↗
Feb 17, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $21.87 — gap to target -22%
Today : $25.93 — gap to target -34%
🎯 on BAX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
▲ Overweight · 🎯$25
Price at call : $20.74 — upside +21%
Today : $25.93 — upside -4%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Overweight · 🎯$30
Price at call : $20.15 — upside +49%
Today : $25.93 — upside +16%
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
Morgan Stanley ↗
Dec 2, 25
▼ Underweight · 🎯$15
Price at call : $18.89 — upside -21%
Today : $25.93 — upside -42%
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $18.21 — gap to target +15%
Today : $25.93 — gap to target -19%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Goldman Sachs ↗
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $18.21 — gap to target +21%
Today : $25.93 — gap to target -15%
🎯 on BAX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $18.21 — gap to target +15%
Today : $25.93 — gap to target -19%
🎯 on BAX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Argus Research ↗
Oct 31, 25
■ Hold neutral · not a buy
🎯 on BAX : no call matured yet · 📊 on Health : 55.7% · +2.6% (158 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$31
Price at call : $22.75 — upside +36%
Today : $25.93 — upside +20%
🎯 on BAX : 0% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
▲ Overweight · 🎯$36
Price at call : $22.84 — upside +58%
Today : $25.93 — upside +39%
Expected +58% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
+19.7%
stock +20% · XLV +24%
matured Aug 4, 26
■ Hold neutral · not a buy · 🎯$25
Price at call : $22.84 — gap to target +9%
Today : $25.93 — gap to target -4%
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.84 — gap to target +5%
Today : $25.93 — gap to target -7%
🎯 on BAX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
Wells Fargo ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $22.44 — gap to target +7%
Today : $25.93 — gap to target -7%
🎯 on BAX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
Morgan Stanley ↗
Jul 15, 25
▼ Underweight · 🎯$27
Price at call : $28.25 — upside -4%
Today : $25.93 — upside +4%
Expected -4% · Actual -22% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+21.6%
stock -22% · XLV +19%
matured Jul 15, 26
■ Neutral neutral · not a buy · 🎯$32
Price at call : $29.7 — gap to target +8%
Today : $25.93 — gap to target +23%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$42
Price at call : $30.66 — upside +37%
Today : $25.93 — upside +62%
Expected +37% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 0% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-28.3%
stock -28% · XLV +20%
matured Jul 8, 26
Morgan Stanley ↗
May 5, 25
▼ Underweight · 🎯$28
Price at call : $29.93 — upside -6%
Today : $25.93 — upside +8%
Expected -6% · Actual -43% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+43.3%
stock -43% · XLV +8%
matured May 5, 26
Wells Fargo ↗
May 2, 25
■ Equal-Weight neutral · not a buy · 🎯$33
Price at call : $30.43 — gap to target +8%
Today : $25.93 — gap to target +27%
🎯 on BAX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
▲ Overweight · 🎯$41
Price at call : $36.56 — upside +12%
Today : $25.93 — upside +58%
Expected +12% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
-52.2%
stock -52% · XLV +4%
matured Mar 10, 26
■ Neutral neutral · not a buy · 🎯$36
Price at call : $35.08 — gap to target +3%
Today : $25.93 — gap to target +39%
🎯 on BAX : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 21, 26
matures : Feb 21, 26
■ Neutral neutral · not a buy · 🎯$35
Price at call : $30.84 — gap to target +13%
Today : $25.93 — gap to target +35%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Dec 11, 25
matures : Dec 11, 25
▲ Buy · 🎯$38
Price at call : $33.83 — upside +12%
Today : $25.93 — upside +47%
Expected +12% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 0% (1 call matured) · 📊 on Health : 51.2% · +8.1% (299 calls)
-44.7%
stock -45% · XLV +4%
matured Nov 11, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $35.97 — gap to target +11%
Today : $25.93 — gap to target +54%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 1, 25
matures : Oct 1, 25
Goldman Sachs ↗
Aug 8, 24
■ Neutral neutral · not a buy · 🎯$40
Price at call : $37.15 — gap to target +8%
Today : $25.93 — gap to target +54%
🎯 on BAX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
■ Neutral neutral · not a buy · 🎯$42
Price at call : $37.42 — gap to target +12%
Today : $25.93 — gap to target +62%
🎯 on BAX : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
Wells Fargo ↗
Aug 7, 24
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $37.42 — gap to target +7%
Today : $25.93 — gap to target +54%
🎯 on BAX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 7, 25
matures : Aug 7, 25
Morgan Stanley ↗
Jul 15, 24
▼ Underweight · 🎯$30
Price at call : $33.97 — upside -12%
Today : $25.93 — upside +16%
Expected -12% · Actual -17% · Reason (≤ −15%) : ✓ Yes
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+16.8%
stock -17% · XLV -10%
matured Jul 15, 25
■ Neutral neutral · not a buy · 🎯$37
Price at call : $35.22 — gap to target +5%
Today : $25.93 — gap to target +43%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 11, 25
matures : Jul 11, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$45
Price at call : $33.16 — upside +36%
Today : $25.93 — upside +74%
Expected +36% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 0% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
-6.5%
stock -6% · XLV -5%
matured Jul 2, 25
Goldman Sachs ↗
May 30, 24
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.43 — gap to target +8%
Today : $25.93 — gap to target +39%
🎯 on BAX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : May 30, 25
matures : May 30, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $34 — gap to target +12%
Today : $25.93 — gap to target +47%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 22, 25
matures : May 22, 25
■ Hold neutral · not a buy · 🎯$40
Price at call : $35.69 — gap to target +12%
Today : $25.93 — gap to target +54%
🎯 on BAX : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
■ Neutral neutral · not a buy · 🎯$44
Price at call : $42.63 — gap to target +3%
Today : $25.93 — gap to target +70%
🎯 on BAX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 3, 25
matures : Apr 3, 25
B of A Securities ↗
Mar 5, 24
■ Neutral neutral · not a buy · 🎯$45
Price at call : $42.99 — gap to target +5%
Today : $25.93 — gap to target +74%
🎯 on BAX : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Mar 5, 25
matures : Mar 5, 25
▲ Overweight · 🎯$54
Price at call : $39.62 — upside +36%
Today : $25.93 — upside +108%
Expected +36% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BAX : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
-23.5%
stock -24% · XLV +2%
matured Feb 11, 25
■ Neutral neutral · not a buy · 🎯$44
Price at call : $40.31 — gap to target +9%
Today : $25.93 — gap to target +70%
🎯 on BAX : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 8, 25
matures : Feb 8, 25
Morgan Stanley ↗
Dec 4, 23
■ Equal-Weight neutral · not a buy · 🎯$39
Price at call : $36.89 — gap to target +6%
Today : $25.93 — gap to target +50%
🎯 on BAX : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 3, 24
matures : Dec 3, 24
Frequently asked questions
Should I buy Baxter International stock?
This isn't buy advice. For Baxter International, the analyst consensus is "Hold", with an average price target of $26.00 (+0% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Baxter International). We show the numbers — you decide.
Is it too late to buy Baxter International? How high can it go?
The most bullish analyst target on Baxter International is $29.00 (+12% above today's price); the average is $26.00. That's the upside they see. Check how reliable those analysts have actually been on Baxter International on our site before trusting it.
Is Baxter International still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Baxter International, the best hitting 100% over 5 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Baxter International? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BAX (and why hesitate).
What has Baxter International's past performance been?
Historical returns and a "how much if I had invested" calculator: BAX performance & returns.
Does Baxter International pay a dividend?
Yield, consistency and growth history of the dividend: BAX's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX